Describes antibody‑modified lipid nanoparticles that deliver genetic edits directly to human haematopoietic stem cells in bone marrow, enabling in vivo modification.
Key Takeaways
- Article CAS PubMed Google Scholar Beck, A., Goetsch, L., Dumontet, C
- Article CAS PubMed Google Scholar Lin, Y., Cheng, Q
- Article PubMed PubMed Central Google Scholar Du, J